SHARE
Insomnia Market

Insomnia Market Forecasts to 2028 – Global Analysis By Type of Diseases (Poor Quality of Sleep, Sleep Maintenance), Route of Administration (Oral Mists, Parenteral) and By Geography

4.3 (45 reviews)
Published: February 2022 ID: SMRC20396
4.3 (45 reviews)
Published: February 2022 ID: SMRC20396

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Insomnia Market is accounted for $5124.04 million in 2021 and is expected to reach $7807.44 million by 2028 growing at a CAGR of 6.2% during the forecast period. Insomnia is a common sleep disorder characterized by difficulties in sleep. Insomnia can exist as alone or conjugated with other psychiatric problems. The exact reason for the cause of insomnia is still unknown. It is most common in women and the severity may increase in conditions like postpartum, menopause and pregnancy. Insomnia disorder can be diagnosed in sleep laboratories using various diagnostic devices.

Market Dynamics:

Driver:

Increasing Stress in Work Place


The work conditions are presently a lot of stress for the employees which is further resulting in tension, constant thinking, and loss of sleep. Also, the market is witnessing a huge demand for OTC drugs amongst the different age groups of patients that are suffering from insomnia. Also, owing to the rising incidence of insomnia amongst people due to numerous reasons like tension and stress is likely to act as major drivers for the global growth of the market.

Restraint:

Lack of Clinical Training 


Lack of in-depth clinical training in current medical curricula has resulted in delayed or misdiagnosed and improper treatment plans for patients. An increased understanding and screening of insomnia disorder by health care professionals could result in broader public knowledge of insomnia disorder and sleep health.

Opportunity:

Development of New Technologies


The development of new technologies and the introduction of medical devices are anticipated to boost the market growth. The major market players are playing a significant role in the market. For instance, Eisai Co. Ltd received approval from the US Food and Drug Administration (FDA) and the firm launched its in-house discovered orexin receptor antagonist DAYVIGO (lemborexant) CIV for the treatment of adults with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance in the United States.

Threat:

Strict Condition


As insomnia’s drugs can be prescribed by doctors only in special cases and under strict conditions, like morphine. These prescriptions are strictly determined by distribution and storage licenses and laws which act ac a major threat for the growth of the market.

Benzodiazepines segment is expected to be the largest during the forecast period

Benzodiazepines are a type of sedative medication. This means they slow down the body and brain's functions. They can be used to help with anxiety and insomnia (difficult getting to sleep or staying asleep) Benzodiazepines are a group of CNS depressants which induce feelings of calm (anxiolysis), drowsiness and sleep. They act by facilitating the binding of the inhibitory neurotransmitter GABA at various GABA receptors throughout the CNS.

The over-the-counter segment is expected to have the highest CAGR during the forecast period

The over-the-counter sleep aids segment is going to have lucrative growth during the forecast period attributing to the growth of this market includes easier availability, low prices, and publicity regarding the side effects of the prescription sleep aids has also steered the patients towards over-the-counter sleep aid.

Region with highest share:

The North America is projected to hold the highest market share, owing to the growing need for sleep disorder treatment in the US and Canada coupled with the growing prevalence of sleep disorders is driving the market. According to the American Academy of Sleep Medicine 2020, stress can result in adjustment insomnia, which may affect up to 20% of people in the United States each year. Poor sleeping habits in children lead to behavioural insomnia of childhood, affecting 30% of children. Prescription drugs, substance abuse, medical disorders, and mental health conditions cause insomnia, with about 3% of the population having this type of sleep issue. Specific causes include depression, drug withdrawal, obesity, and anaemia.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR. The market expansion in this province can be highly attributed to increased stress level of working population along with shift-work related sleep disorders. Asia-Pacific excluding Japan (APEJ) will also remain a remunerative region for growth of the market Governments in the province are constantly focusing on improving their healthcare system along with the provision of favourable reimbursement policies, which in turn might impact the insomnia market.

Key players in the market:

Some of the key players profiled in the Insomnia Market include Astellas, Biocodex S A, Consumer Healthcare Inc., Dainippon Sumitomo, ECR Pharmaceuticals, Eisai Co., Flynn Pharma, Johnson & Johnson, Meda Consumer Healthcare Inc., Merck & Co. Inc., Neurim, Pernix Therapeutics, Pfizer Inc., Purdue Pharma L.P., Sanofi Pasteur, SkyePharma, Takeda Pharmaceutical Company, Vanda Pharmaceuticals Inc. Zydus Cadila, Minerva Neurosciences Inc.

Key developments:

In in June 2020: Eisai Co. Ltd launched in-house discovered orexin receptor antagonist DAYVIGO (lemborexant) CIV for the treatment of adults with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. All these factors are projected to increase the growth of the insomnia treatment market in the North Amer.

In July 2019: Zydus Cadila launched Ramelteon tablets, used to treat insomnia, in the US market.

In January 2021: Minerva Neurosciences Inc. and Royalty Pharma plc entered into an agreement under which Royalty Pharma will acquire Minerva’s royalty interest in seltorexant. Seltorexant, a selective orexin 2 receptor antagonist, is currently in Phase 3 development for the treatment of major depressive disorder (MDD) with insomnia symptoms.

Type of Therapy’s Covered: 
• Non Pharmacological Therapy
• Pharmacological Therapy 

Type of Disease’s Covered:
• Poor Quality of Sleep
• Sleep Maintenance 

Route of Administrations Covered:
• Oral Mists
• Parenteral
  
Drug Formulations Covered:
• Capsules
• Tablet

Drug Classes Covered:
• Antidepressants
• Benzodiazepines

Applications Covered:
• Female
• Male
• Senior Citizens

Distribution Channels Covered:
• Drug Stores
• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

End Users Covered:
• Homecare
• Medical Devices
• Specialty Clinics

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary   
    
2 Preface   

 2.1 Abstract  
 2.2 Stake Holders  
 2.3 Research Scope  
 2.4 Research Methodology  
  2.4.1 Data Mining 
  2.4.2 Data Analysis 
  2.4.3 Data Validation 
  2.4.4 Research Approach 
 2.5 Research Sources  
  2.5.1 Primary Research Sources 
  2.5.2 Secondary Research Sources 
  2.5.3 Assumptions 
    
3 Market Trend Analysis   
 3.1 Introduction  
 3.2 Drivers  
 3.3 Restraints  
 3.4 Opportunities  
 3.5 Threats  
 3.6 Application Analysis  
 3.7 End User Analysis  
 3.8 Emerging Markets  
 3.9 Impact of Covid-19  
    
4 Porters Five Force Analysis   
 4.1 Bargaining power of suppliers  
 4.2 Bargaining power of buyers  
 4.3 Threat of substitutes  
 4.4 Threat of new entrants  
 4.5 Competitive rivalry  
    
5 Global Insomnia Market, By Type of Therapy   
 5.1 Introduction  
 5.2 Non Pharmacological Therapy  
  5.2.1 Cognitive Behavioral Therapy 
  5.2.2 Hypnotherapy 
  5.2.3 Medical Devices 
 5.3 Pharmacological Therapy  
  5.3.1 Prescription Sleep Aids 
  5.3.2 Over-the-Counter Sleep Aids 
    
6 Global Insomnia Market, By Type of Diseases   
 6.1 Introduction  
 6.2 Poor Quality of Sleep  
 6.3 Sleep Maintenance  
    
7 Global Insomnia Market, By Route of Administration   
 7.1 Introduction  
 7.2 Oral Mists  
 7.3 Parenteral   
    
8 Global Insomnia Market, By Drug Formulation   

 8.1 Introduction  
 8.2 Capsules  
 8.3 Tablet  
    
9 Global Insomnia Market, By Drug Classes   
 9.1 Introduction  
 9.2 Antidepressants  
  9.2.1 Orexin Antagonist 
  9.2.2 Melatonin Antagonist 
 9.3 Benzodiazepines  
    
10 Global Insomnia Market, By Application   
 10.1 Introduction  
 10.2 Female  
 10.3 Male  
 10.4 Senior Citizens  
    
11 Global Insomnia Market, By Distribution Channel   
 11.1 Introduction  
 11.2 Drug Stores  
 11.3 Hospital Pharmacies  
 11.4 Online Pharmacies  
 11.5 Retail Pharmacies  
    
12 Global Insomnia Market, By End User    
 12.1 Introduction  
 12.2 Homecare  
 12.3 Medical Devices  
 12.4 Specialty Clinics  
    
13 Global Insomnia Market, By Geography   
 13.1 Introduction  
 13.2 North America  
  13.2.1 US 
  13.2.2 Canada 
  13.2.3 Mexico 
 13.3 Europe  
  13.3.1 Germany 
  13.3.2 UK 
  13.3.3 Italy 
  13.3.4 France 
  13.3.5 Spain 
  13.3.6 Rest of Europe 
 13.4 Asia Pacific  
  13.4.1 Japan 
  13.4.2 China 
  13.4.3 India 
  13.4.4 Australia 
  13.4.5 New Zealand 
  13.4.6 South Korea 
  13.4.7 Rest of Asia Pacific 
 13.5 South America  
  13.5.1 Argentina 
  13.5.2 Brazil 
  13.5.3 Chile 
  13.5.4 Rest of South America 
 13.6 Middle East & Africa  
  13.6.1 Saudi Arabia 
  13.6.2 UAE 
  13.6.3 Qatar 
  13.6.4 South Africa 
  13.6.5 Rest of Middle East & Africa 
    
14 Key Developments   
 14.1 Agreements, Partnerships, Collaborations and Joint Ventures  
 14.2 Acquisitions & Mergers  
 14.3 New Product Launch  
 14.4 Expansions  
 14.5 Other Key Strategies  
    
15 Company Profiling   
 15.1 Astellas  
 15.2 Biocodex S A  
 15.3 Consumer Healthcare Inc.  
 15.4 Dainippon Sumitomo  
 15.5 ECR Pharmaceuticals  
 15.6 Eisai Co.  
 15.7 Flynn Pharma  
 15.8 Johnson & Johnson  
 15.9 Meda Consumer Healthcare Inc.  
 15.10 Merck & Co. Inc.  
 15.11 Neurim  
 15.12 Pernix Therapeutics  
 15.13 Pfizer Inc.  
 15.14 Purdue Pharma L.P.  
 15.15 Sanofi Pasteur  
 15.16 SkyePharma  
 15.17 Takeda Pharmaceutical Company  
 15.18 Vanda Pharmaceuticals Inc.  
 15.19 Zydus Cadila  
 15.20 Minerva Neurosciences Inc  


List of Tables    
1 Global Insomnia Market Outlook, By Region (2020-2028) (US $MN)    
2 Global Insomnia Market Outlook, By Type of Therapy (2020-2028) (US $MN)   
3 Global Insomnia Market Outlook, By Non Pharmacological Therapy (2020-2028) (US $MN)   
4 Global Insomnia Market Outlook, By Cognitive Behavioral Therapy (2020-2028) (US $MN)   
5 Global Insomnia Market Outlook, By Hypnotherapy (2020-2028) (US $MN)   
6 Global Insomnia Market Outlook, By Medical Devices (2020-2028) (US $MN)   
7 Global Insomnia Market Outlook, By Pharmacological Therapy (2020-2028) (US $MN)   
8 Global Insomnia Market Outlook, By Prescription Sleep Aids (2020-2028) (US $MN)   
9 Global Insomnia Market Outlook, By Over-the-Counter Sleep Aids (2020-2028) (US $MN)   
10 Global Insomnia Market Outlook, By Type of Diseases (2020-2028) (US $MN)   
11 Global Insomnia Market Outlook, By Poor Quality of Sleep (2020-2028) (US $MN)   
12 Global Insomnia Market Outlook, By Sleep Maintenance (2020-2028) (US $MN)   
13 Global Insomnia Market Outlook, By Route of Administration (2020-2028) (US $MN)   
14 Global Insomnia Market Outlook, By Oral Mists (2020-2028) (US $MN)   
15 Global Insomnia Market Outlook, By Parenteral  (2020-2028) (US $MN)   
16 Global Insomnia Market Outlook, By Drug Formulation (2020-2028) (US $MN)   
17 Global Insomnia Market Outlook, By Capsules (2020-2028) (US $MN)   
18 Global Insomnia Market Outlook, By Tablet (2020-2028) (US $MN)   
19 Global Insomnia Market Outlook, By Drug Classes (2020-2028) (US $MN)   
20 Global Insomnia Market Outlook, By Antidepressants (2020-2028) (US $MN)   
21 Global Insomnia Market Outlook, By Orexin Antagonist (2020-2028) (US $MN)   
22 Global Insomnia Market Outlook, By Melatonin Antagonist (2020-2028) (US $MN)   
23 Global Insomnia Market Outlook, By No benzodiazepines (2020-2028) (US $MN)   
24 Global Insomnia Market Outlook, By Application (2020-2028) (US $MN)   
25 Global Insomnia Market Outlook, By Female (2020-2028) (US $MN)   
26 Global Insomnia Market Outlook, By Male (2020-2028) (US $MN)   
27 Global Insomnia Market Outlook, By Senior Citizens (2020-2028) (US $MN)   
28 Global Insomnia Market Outlook, By Distribution Channel (2020-2028) (US $MN)   
29 Global Insomnia Market Outlook, By Drug Stores (2020-2028) (US $MN)   
30 Global Insomnia Market Outlook, By Hospital Pharmacies (2020-2028) (US $MN)   
31 Global Insomnia Market Outlook, By Online Pharmacies (2020-2028) (US $MN)   
32 Global Insomnia Market Outlook, By Retail Pharmacies (2020-2028) (US $MN)   
33 Global Insomnia Market Outlook, By End User (2020-2028) (US $MN)   
34 Global Insomnia Market Outlook, By Homecare (2020-2028) (US $MN)   
35 Global Insomnia Market Outlook, By Medical Devices (2020-2028) (US $MN)   
36 Global Insomnia Market Outlook, By Specialty Clinics (2020-2028) (US $MN)   
    
Note- Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.   

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials